SCHEMBL31657673

SCHEMBL31657673

NC(=O)c1cncc(-c2cc[nH]n2)c1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MKNK1 Q9BUB5 7/20 0.49
▸ MKNK2 Q9HBH9 7/20 0.49
▸ CYP11B2 P19099 3/20 0.48
▸ CYP11B1 P15538 2/20 0.48
▸ MAP4K4 O95819 3/20 0.42
▸ SIRT2 Q8IXJ6 2/20 0.40
▸ SIRT1 Q96EB6 2/20 0.40
▸ SIRT3 Q9NTG7 2/20 0.40
▸ CHRNB4 P30926 2/20 0.40
▸ CHRNA3 P32297 2/20 0.40
▸ DGAT1 O75907 1/20 0.40
▸ PIM1 P11309 1/20 0.39
▸ CDC7 O00311 1/20 0.39
▸ F7 P08709 1/20 0.39
▸ F3 P13726 1/20 0.39
▸ SARM1 Q6SZW1 1/20 0.39
▸ SIRT6 Q8N6T7 1/20 0.39
▸ SIRT5 Q9NXA8 1/20 0.39
▸ SIRT4 Q9Y6E7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7830759 0.84 MKNK1 (0.38) MKNK1MKNK2CYP11B2CYP11B1MAP4K4
SCHEMBL7831294 0.82 CYP11B2 (0.52) CYP11B2CYP11B1
SCHEMBL28303592 0.81 CCNT1 (0.50) PIM1CDC7
SCHEMBL3086806 0.78 MAPK1 (0.48) MKNK1MKNK2MAP4K4
SCHEMBL6754398 0.77 MKNK1 (0.67) MKNK1MKNK2CYP11B2CYP11B1MAP4K4
Hydrochloric Acid SCHEMBL31747485 0.77 MAPK1 (0.47) MKNK1MKNK2MAP4K4
Niacinamide SCHEMBL28655386 0.76 F7 (0.59) MKNK1MKNK2SIRT2SIRT1SIRT3
SCHEMBL4713853 0.73 — —
SCHEMBL4150697 0.73 CDC7 (0.54) MKNK1MKNK2CDC7
SCHEMBL27404904 0.73 ALDH1A1 (0.38) MKNK1MKNK2CYP11B2CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025146653-A1 PROCESS FOR THE PREPARATION OF N- [4(CHLORODIFLUOROMETHOXY)PHENYL]-6-[(3R)-3-HYDROXY PYRROLIDIN-L-YL]-5-(LH-PYRAZOL-3-YL) PYRIDINE-3- CARBOXAMIDE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF BIOPHORE INDIA PHARMACEUTICALS PVT. LTD (IN) 2025-07-10 — — WO disclosed
Send feedback